perrin

Richard Perrin, MD, PhD

Assistant Professor of Pathology & Immunology

Novel cerebrospinal fluid biomarkers for early diagnosis, prognosis, and staging of neurodegenerative diseases
Read More

Email: rperrin@path.wustl.edu
Lab Phone: (314) 747-5713
Website:
Lab Location: BJC-Institute of Health 9th Floor
Keywords: Alzheimer's disease, Lewy body, Parkinson's, Huntington's, Frontotemporal dementia, neurodegeneration, cerebrospinal fluid, proteomics, biomarker

Novel cerebrospinal fluid biomarkers for early diagnosis, prognosis, and staging of neurodegenerative diseases

Fagan & Perrin. (2012) Biomarkers in Medicine

Richard Perrin’s laboratory studies the cerebrospinal fluid proteome to identify new biomarkers for early diagnosis, prognosis, staging and monitoring of neurodegenerative diseases.  Such biomarkers will be essential for maximizing the efficiency, shortening the duration and reducing the cost of clinical trials, and should therefore accelerate the evaluation and discovery of effective treatments.  Additionally, they may provide novel insights into neurodegenerative pathophysiology and suggest unanticipated candidate targets for therapy.

EmailPrintShare
‘s News & Select Publications

Hope Center Affiliations

Publications

Real-time Scopus search

Scopus

.